Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

Neratinib is effective in breast tumors bearing both amplification and mutation of ERBB2 (HER2).

Cocco E, Javier Carmona F, Razavi P, Won HH, Cai Y, Rossi V, Chan C, Cownie J, Soong J, Toska E, Shifman SG, Sarotto I, Savas P, Wick MJ, Papadopoulos KP, Moriarty A, Cutler RE Jr, Avogadri-Connors F, Lalani AS, Bryce RP, Chandarlapaty S, Hyman DM, Solit DB, Boni V, Loi S, Baselga J, Berger MF, Montemurro F, Scaltriti M.

Sci Signal. 2018 Oct 9;11(551). pii: eaat9773. doi: 10.1126/scisignal.aat9773.

PMID:
30301790
2.

The expression of LINE1-MET chimeric transcript identifies a subgroup of aggressive breast cancers.

Miglio U, Berrino E, Panero M, Ferrero G, Coscujuela Tarrero L, Miano V, Dell'Aglio C, Sarotto I, Annaratone L, Marchiò C, Comoglio PM, De Bortoli M, Pasini B, Venesio T, Sapino A.

Int J Cancer. 2018 Aug 25. doi: 10.1002/ijc.31831. [Epub ahead of print]

PMID:
30144023
3.

Rituximab Treatment Prevents Lymphoma Onset in Gastric Cancer Patient-Derived Xenografts.

Corso S, Cargnelutti M, Durando S, Menegon S, Apicella M, Migliore C, Capeloa T, Ughetto S, Isella C, Medico E, Bertotti A, Sassi F, Sarotto I, Casorzo L, Pisacane A, Mangioni M, Sottile A, Degiuli M, Fumagalli U, Sgroi G, Molfino S, De Manzoni G, Rosati R, De Simone M, Marrelli D, Saragoni L, Rausei S, Pallabazzer G, Roviello F, Cassoni P, Sapino A, Bass A, Giordano S.

Neoplasia. 2018 May;20(5):443-455. doi: 10.1016/j.neo.2018.02.003. Epub 2018 Mar 23.

4.

Colorectal cancer early methylation alterations affect the crosstalk between cell and surrounding environment, tracing a biomarker signature specific for this tumor.

Fadda A, Gentilini D, Moi L, Barault L, Leoni VP, Sulas P, Zorcolo L, Restivo A, Cabras F, Fortunato F, Zavattari C, Varesco L, Gismondi V, De Miglio MR, Scanu AM, Colombi F, Lombardi P, Sarotto I, Loi E, Leone F, Giordano S, Di Nicolantonio F, Columbano A, Zavattari P.

Int J Cancer. 2018 Aug 15;143(4):907-920. doi: 10.1002/ijc.31380. Epub 2018 Apr 6.

PMID:
29542109
5.

Genotyping tumour DNA in cerebrospinal fluid and plasma of a HER2-positive breast cancer patient with brain metastases.

Siravegna G, Geuna E, Mussolin B, Crisafulli G, Bartolini A, Galizia D, Casorzo L, Sarotto I, Scaltriti M, Sapino A, Bardelli A, Montemurro F.

ESMO Open. 2017 Oct 9;2(4):e000253. doi: 10.1136/esmoopen-2017-000253. eCollection 2017.

6.

The impact of malignant nipple discharge cytology (NDc) in surgical management of breast cancer patients.

Castellano I, Metovic J, Balmativola D, Annaratone L, Rangel N, Vissio E, Arisio R, Macrì L, Pecchioni C, Sarotto I, Montarolo F, Muscarà F, Marchiò C, Cassoni P, Kulka J, Sapino A.

PLoS One. 2017 Aug 14;12(8):e0182073. doi: 10.1371/journal.pone.0182073. eCollection 2017.

7.

Efficacy of NEDD8 Pathway Inhibition in Preclinical Models of Poorly Differentiated, Clinically Aggressive Colorectal Cancer.

Picco G, Petti C, Sassi F, Grillone K, Migliardi G, Rossi T, Isella C, Di Nicolantonio F, Sarotto I, Sapino A, Bardelli A, Trusolino L, Bertotti A, Medico E.

J Natl Cancer Inst. 2016 Oct 22;109(2). pii: djw209. Print 2017 Feb.

8.

Dual MET/EGFR therapy leads to complete response and resistance prevention in a MET-amplified gastroesophageal xenopatient cohort.

Apicella M, Migliore C, Capelôa T, Menegon S, Cargnelutti M, Degiuli M, Sapino A, Sottile A, Sarotto I, Casorzo L, Cassoni P, De Simone M, Comoglio PM, Marsoni S, Corso S, Giordano S.

Oncogene. 2017 Mar 2;36(9):1200-1210. doi: 10.1038/onc.2016.283. Epub 2016 Aug 15.

PMID:
27524418
9.

Establishment of a patient-derived intrahepatic cholangiocarcinoma xenograft model with KRAS mutation.

Cavalloni G, Peraldo-Neia C, Sassi F, Chiorino G, Sarotto I, Aglietta M, Leone F.

BMC Cancer. 2016 Feb 11;16:90. doi: 10.1186/s12885-016-2136-1.

10.

Aurora kinase A gene copy number is associated with the malignant transformation of colorectal adenomas but not with the serrated neoplasia progression.

Casorzo L, Dell'Aglio C, Sarotto I, Risio M.

Hum Pathol. 2015 Mar;46(3):411-8. doi: 10.1016/j.humpath.2014.11.016. Epub 2014 Dec 10.

PMID:
25596657
11.

Tumour budding is associated with hypoxia at the advancing front of colorectal cancer.

Righi A, Sarotto I, Casorzo L, Cavalchini S, Frangipane E, Risio M.

Histopathology. 2015 Jun;66(7):982-90. doi: 10.1111/his.12602. Epub 2015 Feb 4.

PMID:
25381897
12.

TNF-α promotes invasive growth through the MET signaling pathway.

Bigatto V, De Bacco F, Casanova E, Reato G, Lanzetti L, Isella C, Sarotto I, Comoglio PM, Boccaccio C.

Mol Oncol. 2015 Feb;9(2):377-88. doi: 10.1016/j.molonc.2014.09.002. Epub 2014 Sep 26.

13.

A founder MLH1 mutation in Lynch syndrome families from Piedmont, Italy, is associated with an increased risk of pancreatic tumours and diverse immunohistochemical patterns.

Borelli I, Casalis Cavalchini GC, Del Peschio S, Micheletti M, Venesio T, Sarotto I, Allavena A, Delsedime L, Barberis MA, Mandrile G, Berchialla P, Ogliara P, Bracco C, Pasini B.

Fam Cancer. 2014 Sep;13(3):401-13. doi: 10.1007/s10689-014-9726-3.

14.

Cytokine-induced killer cells eradicate bone and soft-tissue sarcomas.

Sangiolo D, Mesiano G, Gammaitoni L, Leuci V, Todorovic M, Giraudo L, Cammarata C, Dell'Aglio C, D'Ambrosio L, Pisacane A, Sarotto I, Miano S, Ferrero I, Carnevale-Schianca F, Pignochino Y, Sassi F, Bertotti A, Piacibello W, Fagioli F, Aglietta M, Grignani G.

Cancer Res. 2014 Jan 1;74(1):119-29. doi: 10.1158/0008-5472.CAN-13-1559. Epub 2013 Dec 19.

15.

Moderate immunohistochemical expression of HER-2 (2+) without HER-2 gene amplification is a negative prognostic factor in early breast cancer.

Rossi V, Sarotto I, Maggiorotto F, Berchialla P, Kubatzki F, Tomasi N, Redana S, Martinello R, Valabrega G, Aglietta M, Ponzone R, Montemurro F.

Oncologist. 2012;17(11):1418-25. doi: 10.1634/theoncologist.2012-0194. Epub 2012 Sep 4.

16.

Omission of axillary dissection after a positive sentinel node dissection may influence adjuvant chemotherapy indications in operable breast cancer patients.

Montemurro F, Maggiorotto F, Valabrega G, Kubatzki F, Rossi V, Magistris A, Marocco F, Gatti M, Sarotto I, Aglietta M, Ponzone R.

Ann Surg Oncol. 2012 Nov;19(12):3755-61. doi: 10.1245/s10434-012-2505-1. Epub 2012 Jul 18.

PMID:
22805871
17.

Antitumor activity of Src inhibitor saracatinib (AZD-0530) in preclinical models of biliary tract carcinomas.

Cavalloni G, Peraldo-Neia C, Sarotto I, Gammaitoni L, Migliardi G, Soster M, Marchiò S, Aglietta M, Leone F.

Mol Cancer Ther. 2012 Jul;11(7):1528-38. doi: 10.1158/1535-7163.MCT-11-1020. Epub 2012 Mar 27.

18.

Correlations between diffusion-weighted imaging and breast cancer biomarkers.

Martincich L, Deantoni V, Bertotto I, Redana S, Kubatzki F, Sarotto I, Rossi V, Liotti M, Ponzone R, Aglietta M, Regge D, Montemurro F.

Eur Radiol. 2012 Jul;22(7):1519-28. doi: 10.1007/s00330-012-2403-8. Epub 2012 Mar 13.

PMID:
22411304
19.

MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer.

Migliore C, Martin V, Leoni VP, Restivo A, Atzori L, Petrelli A, Isella C, Zorcolo L, Sarotto I, Casula G, Comoglio PM, Columbano A, Giordano S.

Clin Cancer Res. 2012 Feb 1;18(3):737-47. doi: 10.1158/1078-0432.CCR-11-1699. Epub 2011 Dec 16.

20.

Yes-associated protein regulation of adaptive liver enlargement and hepatocellular carcinoma development in mice.

Kowalik MA, Saliba C, Pibiri M, Perra A, Ledda-Columbano GM, Sarotto I, Ghiso E, Giordano S, Columbano A.

Hepatology. 2011 Jun;53(6):2086-96. doi: 10.1002/hep.24289. Epub 2011 May 13.

21.

Targeting EGFR/HER2 pathways enhances the antiproliferative effect of gemcitabine in biliary tract and gallbladder carcinomas.

Pignochino Y, Sarotto I, Peraldo-Neia C, Penachioni JY, Cavalloni G, Migliardi G, Casorzo L, Chiorino G, Risio M, Bardelli A, Aglietta M, Leone F.

BMC Cancer. 2010 Nov 18;10:631. doi: 10.1186/1471-2407-10-631.

22.

Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice.

Casazza A, Finisguerra V, Capparuccia L, Camperi A, Swiercz JM, Rizzolio S, Rolny C, Christensen C, Bertotti A, Sarotto I, Risio M, Trusolino L, Weitz J, Schneider M, Mazzone M, Comoglio PM, Tamagnone L.

J Clin Invest. 2010 Aug;120(8):2684-98. doi: 10.1172/JCI42118. Epub 2010 Jul 26. Erratum in: J Clin Invest. 2011 Jul 1;121(7):2945. Mazzone, Massimilano [corrected to Mazzone, Massimiliano].

23.

Granulocyte-colony stimulating factor upregulates ErbB2 expression on breast cancer cell lines and converts primary resistance to trastuzumab.

Cavalloni G, Sarotto I, Pignochino Y, Gammaitoni L, Migliardi G, Sgro L, Piacibello W, Risio M, Aglietta M, Leone F.

Anticancer Drugs. 2008 Aug;19(7):689-96. doi: 10.1097/CAD.0b013e3283050083.

PMID:
18594210
24.

Extra-nuclear signalling of estrogen receptor to breast cancer cytoskeletal remodelling, migration and invasion.

Giretti MS, Fu XD, De Rosa G, Sarotto I, Baldacci C, Garibaldi S, Mannella P, Biglia N, Sismondi P, Genazzani AR, Simoncini T.

PLoS One. 2008 May 21;3(5):e2238. doi: 10.1371/journal.pone.0002238.

25.

In melanocytic lesions the fraction of BRAF V600E alleles is associated with sun exposure but unrelated to ERK phosphorylation.

Venesio T, Chiorino G, Balsamo A, Zaccagna A, Petti C, Scatolini M, Pisacane A, Sarotto I, Picciotto F, Risio M.

Mod Pathol. 2008 Jun;21(6):716-26. doi: 10.1038/modpathol.2008.41. Epub 2008 Apr 11.

26.

Relationship between DCE-MRI morphological and functional features and histopathological characteristics of breast cancer.

Montemurro F, Martincich L, Sarotto I, Bertotto I, Ponzone R, Cellini L, Redana S, Sismondi P, Aglietta M, Regge D.

Eur Radiol. 2007 Jun;17(6):1490-7. Epub 2006 Dec 6.

PMID:
17149623
27.

Somatic mutations of epidermal growth factor receptor in bile duct and gallbladder carcinoma.

Leone F, Cavalloni G, Pignochino Y, Sarotto I, Ferraris R, Piacibello W, Venesio T, Capussotti L, Risio M, Aglietta M.

Clin Cancer Res. 2006 Mar 15;12(6):1680-5.

28.

Serum bile acids, programmed cell death and cell proliferation in the mucosa of patients with colorectal adenomas.

Fracchia M, Galatola G, Sarotto I, Guraldo V, Perona M, Pera A, Risio M.

Dig Liver Dis. 2005 Jul;37(7):509-14. Epub 2005 Mar 29.

PMID:
15975538
29.

TGFalpha expression impairs Trastuzumab-induced HER2 downregulation.

Valabrega G, Montemurro F, Sarotto I, Petrelli A, Rubini P, Tacchetti C, Aglietta M, Comoglio PM, Giordano S.

Oncogene. 2005 Apr 21;24(18):3002-10.

PMID:
15735715
30.

Pretreatment serum hemoglobin level and a preliminary investigation of intratumoral microvessel density in advanced ovarian cancer.

Ferrero A, Zola P, Mazzola S, Fuso L, Sarotto I, Ravarino N, Spanu PG, Jacomuzzi ME, Carus AP, Sismondi P.

Gynecol Oncol. 2004 Nov;95(2):323-9.

31.

HER2 and central nervous system metastasis in patients with breast cancer.

Montemurro F, Sarotto I, Casorzo L, Pisacane A, Aglietta M, De Rosa G.

Clin Breast Cancer. 2004 Aug;5(3):232-4.

PMID:
15335457
32.

Monitoring response to primary chemotherapy in breast cancer using dynamic contrast-enhanced magnetic resonance imaging.

Martincich L, Montemurro F, De Rosa G, Marra V, Ponzone R, Cirillo S, Gatti M, Biglia N, Sarotto I, Sismondi P, Regge D, Aglietta M.

Breast Cancer Res Treat. 2004 Jan;83(1):67-76.

PMID:
14997056
33.

HER2 testing in gastric cancer: molecular morphology and storage time-related changes in archival samples.

Risio M, De Rosa G, Sarotto I, Casorzo L, Capussotti L, Torchio B, Aglietta M, Chiecchio L.

Int J Oncol. 2003 Nov;23(5):1381-7.

PMID:
14532980
34.

Programmed cell death, proliferating cell nuclear antigen and p53 expression in mouse colon mucosa during diet-induced tumorigenesis.

Risio M, Sarotto I, Rossini FP, Newmark H, Yang K, Lipkin M.

Anal Cell Pathol. 2000;21(2):87-94.

35.

Resveratrol depresses the growth of colorectal aberrant crypt foci by affecting bax and p21(CIP) expression.

Tessitore L, Davit A, Sarotto I, Caderni G.

Carcinogenesis. 2000 Aug;21(8):1619-22.

PMID:
10910967
36.

Bcl2, p53 and clinical outcome in a series of 138 operable breast cancer patients.

Castiglione F, Sarotto I, Fontana V, Destefanis M, Venturino A, Ferro S, Cardaropoli S, Orengo MA, Porcile G.

Anticancer Res. 1999 Sep-Oct;19(5C):4555-63.

PMID:
10650810
37.

Gastrointestinal stromal tumor, uncommitted type, with monosomies 14 and 22 as the only chromosomal abnormalities.

Marci V, Casorzo L, Sarotto I, Dogliani N, Milazzo MG, Risio M.

Cancer Genet Cytogenet. 1998 Apr 15;102(2):135-8.

PMID:
9546066
38.

[Relation between chronic antral gastritis and the presence of Campylobacter pyloridis. Retrospective study on a geriatric population].

D'Amore V, Prandi GC, Bianco R, Sarotto I, Fessia L.

Minerva Dietol Gastroenterol. 1988 Apr-Jun;34(2):73-8. Italian. No abstract available.

PMID:
3173758

Supplemental Content

Loading ...
Support Center